Patent-filing research conducted by Withers & Rogers suggests that CAR T-cell therapy capability has reached a pivotal point on route to market, and first-line use of these promising treatments for various forms of cancer is nearing.
Patent-filing research conducted by Withers & Rogers suggests that CAR T-cell therapy capability has reached a pivotal point on route to market, and first-line use of these promising treatments for various forms of cancer is nearing, although it’s still not clear how long it will take.
Withers & Rogers
The week's biggest stories from this industry, direct to your inbox.
